Stock Code: 000028/200028 Notice No.: 2021-34

Short Form of the Stock: Sinopharm Accord /Accord B

China National Accord Medicines Corporation Ltd.Summary of Semi-Annual Report 2021

I. Important Notice

The summary of semi-annual report is excerpted from the full text of the semi-annual report. For the details investors should

carefully read the full text of the semi-annual report published on Juchao Information website (www.cninfo.com.cn) and Shenzhen

Stock Exchange Website etc. appointed by CSRC.Other directors attending the Meeting for semi-annual report deliberation except for the followed

Name of director absent Title for absent director Reasons for absent Attorney

Prompt of modified auditing opinion

□ Applicable √ Not applicable

Profit distribution pre-plan of common stock or capitalizing of common reserves pre-plan deliberated by the Board in the reporting

period

□ Applicable √ Not applicable

The Company plans not to carry out cash dividend and bonus distribution and capitalizing of common reserves

Profit distribution pre-plan of preferred stock deliberated and approved by the Board in the reporting period

□ Applicable √ Not applicable

II. Basic information of the company

1. Company profile

Short form of the stock Sinopharm Accord Accord B Stock code 000028 200028

Stock exchange for listing Shenzhen Stock Exchange

Person/Way to contact Secretary of the Board Rep. of security affairs

Name Chen Changbing Wang Zhaoyu

Accord Pharm. Bldg. No. 15 Ba Gua Si Accord Pharm. Bldg. No. 15 Ba Gua Si

Office add. Road Futian District Shenzhen Guangdong Road Futian District Shenzhen Guangdong

Province Province

Tel. +(86)755 25875195 +(86)755 25875222

E-mail gyyzinvestor@sinopharm.com gyyz0028@sinopharm.com

2. Main financial data and index

Whether it has retroactive adjustment or re-statement on previous accounting data

□ Yes √ No

Increase/decrease in this

Current Period Same period of last year

report y-o-y

Operating revenue (RMB) 33163091887.39 27169940188.52 22.06%

Net profit attributable to shareholders of

741445013.25 643451580.59 15.23%

the listed Company (RMB)

Net profit attributable to shareholders of

the listed Company after deducting 720954408.22 627017019.45 14.98%

non-recurring gains and losses (RMB)

Net cash flow arising from operating

1229373283.57 1438204043.35 -14.52%

activities (RMB)

Basic earnings per share (RMB/Share)

1.73 1.50 15.33%

(note 1)

Diluted earnings per share (RMB/Share) 1.73 1.50 15.33%

Weighted average ROE Increase 0.31 percentage p5.22% 4.91%

oints

Increase/decrease in this

End of current period End of last period report-end over that of last

period-end (+-)

Total assets (RMB) 44190878403.95 39594533471.65 11.61%

Net assets attributable to shareholder of

14346870065.79 13948322652.33 2.86%

listed Company (RMB)

3. Number of shareholders and share-holding

Unit: share

Total preference shareholders

Total common shareholders at with voting rights recovered at

43600 0

period-end end of reporting period (if

applicable)

Top ten shareholders

Information of shares

Full name of Nature of Proportion of Amount of

Amount of restricted shares held pledged tagged or frozen

Shareholders shareholder shares held shares held

State of share Amount

Sinopharm State-owned

56.06% 239999991 5505770

Group Co. Ltd. Corporation

FIRST

SENTIER

INVESTORS

GLOBAL

Foreign

UMBRELLA 2.68% 11469644

Corporation

FUND PLC -

FSSA CHINA

GROWTH

FUND

Hong Kong

Securities Foreign

2.58% 11033948

Clearing Corporation

Company Ltd

China National

Pharmaceutical State-owned

1.24% 5323043

Foreign Trade Corporation

Corp.National Social Domestic non

Security Fund state-owned 0.98% 4200032

413 Portfolio Corporation

BBH BOS S/A

FIDELITY FD - Foreign

0.78% 3358761

CHINA FOCUS Corporation

FD

China

Construction

Bank Domestic non

Corporation state-owned 0.73% 3111875

-China Europe Corporation

Value Discovery

Equity Fund

CPIC Fund

-China Pacific

Life Insurance

Co. Ltd. -

with-profit

insurance- CPIC

Fund China Domestic non

Pacific Life state-owned 0.66% 2822801

Equity Relative Corporation

Income

(Guaranteed

Dividend)

single assets

management

plan

Fidelity

Investment

Management Foreign

0.54% 2308237

(Hong Kong) Corporation

Limited -

Client’s fund

VANGUARD

EMERGING

Foreign

MARKETS 0.41% 1756387

Corporation

STOCK INDEX

FUND

Sinopharm Group Co. Ltd. and China National Pharmaceutical Foreign Trade Corporation have

Explanation on associated the same actual controller which is China National Pharmaceutical Group Corporation. It is

relationship among the aforesaid unknown that there exists no associated relationship or belongs to the consistent actionist among

shareholders the other tradable shareholders regulated by the Management Measure of Information Disclosure

on Change of Shareholding for Listed Companies.4. Changes of controlling shareholders or actual controller

Changes of controlling shareholders in reporting period

□ Applicable √ Not applicable

Changes of controlling shareholders had no change in reporting period.Changes of actual controller in reporting period

□ Applicable √ Not applicable

Changes of actual controller had no change in reporting period.5. Total preferred stock shareholders of the Company and shares held by top ten shareholders with

preferred stock held

□ Applicable √ Not applicable

The Company had no shareholders with preferred stock held in the reporting.6. Bonds in existence as of the approval date of the semi-annual report

□ Applicable √ Not applicable

III. Important events

Nil